Citation Impact
Citing Papers
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.
1993
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
2000
p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor
1992
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
2009
PROGNOSTIC SIGNIFICANCE OF THE CO-EXPRESSION OF p53 AND c-erbB-2 PROTEINS IN BREAST CANCER
1996
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer
1999
Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
2002
The relationship between prognostic and predictive factors in the management of breast cancer
1998
EXPRESSION OF THE TYPE 1 TYROSINE KINASE GROWTH FACTOR RECEPTORS EGF RECEPTOR, c-erbB2 AND c-erbB3 IN BLADDER CANCER
1996
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma
2002
Focused Microwave Phased Array Thermotherapy for Ablation of Early-Stage Breast Cancer: Results of Thermal Dose Escalation
2004
The antioxidant role of selenium and seleno-compounds
2003 Standout
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
2009 Standout
Apoptosis in cancer
2000 Standout
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Oncogenic kinase signalling
2001 StandoutNature
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
The Role of the p53 Tumor Suppressor Gene in Squamous Cell Carcinoma of the Head and Neck
1993
Renal-Cell Carcinoma
1996 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types
1998
The Epigenomics of Cancer
2007 Standout
The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum
2003 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
Activation of transcription factors AP-1 and NF-κB in chronic cyclosporine A nephrotoxicity: role in beneficial effects of magnesium supplementation1
2003 StandoutNobel
Pathological prognostic factors in breast cancer
1999 Standout
Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma
1995
Genome changes and gene expression in human solid tumors
2000
p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry
1996
The essence of senescence: Figure 1.
2010 Standout
Expression of Stress-Response and Cell Proliferation Genes in Renal Cell Carcinoma Induced by Oxidative Stress
2000
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Apoptosis
2002 Standout
The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus Immunohistochemistry
1996
Involvement of Ets Transcription Factors and Targets in Osteoblast Differentiation and Matrix Mineralization
2000
A large-scale study of the ultrawideband microwave dielectric properties of normal, benign and malignant breast tissues obtained from cancer surgeries
2007 Standout
Regulation of Mouse Mammary Gland Development and Tumorigenesis by the ERBB Signaling Network
2001
PI3K/Akt signalling pathway and cancer
2003 Standout
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo
2005
Clinical implications of p53 mutations
1999
From catalytic asymmetric synthesis to the transcriptional regulation of genes: In vivo and in vitro evolution of proteins
2001 StandoutNobel
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
1995
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence
2010
Cancer epigenomics: DNA methylomes and histone-modification maps
2007 Standout
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
The IGF system and breast cancer.
2001
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
PI3K-Akt pathway: Its functions and alterations in human cancer
2004 Standout
Perineural invasion in cancer
2009 Standout
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
2010 Standout
THE PATHOLOGICAL AND BIOLOGICAL NATURE OF SCREEN‐DETECTED BREAST CARCINOMAS: A MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY
1997
Anticancer potential of curcumin: preclinical and clinical studies.
2003 Standout
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Erbb4 Signaling in the Mammary Gland Is Required for Lobuloalveolar Development and Stat5 Activation during Lactation
1999
Type 1 growth factor receptors: an overview of recent developments
1995
Characterization of Insulin-Like Growth Factor-Binding Protein-Related Proteins (IGFBP-rPs) 1, 2, and 3 in Human Prostate Epithelial Cells: Potential Roles for IGFBP-rP1 and 2 in Senescence of the Prostatic Epithelium*
2000
The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily*
1999
Annexins: From Structure to Function
2002 Standout
Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?
1993
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Predictors of local recurrence after treatment of ductal carcinoma in situ
1999
A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.
1999
Works of J.L. Ostrowski being referenced
c‐erbB‐3 protein expression in human breast cancer: comparison with other tumour variables and survival
1994
Ductal carcinoma in situ of the breast: the clinical significance of histological classification
1997
Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas
1998
Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: An immunohistochemical study
1992
p53 expression in human breast cancer related to survival and prognostic factors: An immunohistochemical study
1991
Invasive ductal carcinoma accompanied by ductal carcinoma in situ (DCIS): comparison of DCIS grade with grade of invasive component
1997